These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 14679436)

  • 1. [Giant cell tumor of bone. An evaluation of 87 patients].
    Tunn PU; Schlag PM
    Z Orthop Ihre Grenzgeb; 2003; 141(6):690-8. PubMed ID: 14679436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical observation of surgical management for recurrent giant cell tumor of bone].
    Kong Q; Yang J; Xing R; Tu C; Zhou Y; Zhang H; Duan H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jan; 27(1):36-40. PubMed ID: 23427489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended intralesional curettage preferred over resection-arthrodesis for giant cell tumour of the distal radius.
    Abuhejleh H; Wunder JS; Ferguson PC; Isler MH; Mottard S; Werier JA; Griffin AM; Turcotte RE
    Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):11-17. PubMed ID: 31297594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Giant cell tumour of bone in the appendicular skeleton: an analysis of 276 cases.
    Xing R; Yang J; Kong Q; Tu C; Zhou Y; Duan H
    Acta Orthop Belg; 2013 Dec; 79(6):731-7. PubMed ID: 24563982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis of 51 intralesionally treated cases with progressed giant cell tumor of the bone: local adjuvant use of hydrogen peroxide reduces the risk for tumor recurrence.
    Omlor GW; Lange J; Streit M; Gantz S; Merle C; Germann T; Mechtersheimer G; Fellenberg J; Lehner B
    World J Surg Oncol; 2019 Apr; 17(1):73. PubMed ID: 31014317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Giant cell tumor of bone: risk factors for recurrence.
    Klenke FM; Wenger DE; Inwards CY; Rose PS; Sim FH
    Clin Orthop Relat Res; 2011 Feb; 469(2):591-9. PubMed ID: 20706812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study.
    Tse LF; Wong KC; Kumta SM; Huang L; Chow TC; Griffith JF
    Bone; 2008 Jan; 42(1):68-73. PubMed ID: 17962092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgical treatment for long bone giant cell tumor of extremity with pathologic fracture].
    Li X; Guo W; Yang Y; Wei R; DU ZY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Oct; 45(5):745-51. PubMed ID: 24136271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher local recurrence rates after intralesional surgery for giant cell tumor of the proximal femur compared to other sites.
    Errani C; Tsukamoto S; Leone G; Akahane M; Cevolani L; Tanzi P; Kido A; Honoki K; Tanaka Y; Donati DM
    Eur J Orthop Surg Traumatol; 2017 Aug; 27(6):813-819. PubMed ID: 28589498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery methods and soft tissue extension are the potential risk factors of local recurrence in giant cell tumor of bone.
    Li D; Zhang J; Li Y; Xia J; Yang Y; Ren M; Liao Y; Yu S; Li X; Shen Y; Zhang Y; Yang Z
    World J Surg Oncol; 2016 Apr; 14():114. PubMed ID: 27094617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Giant cell tumors of the bones of the hand.
    Athanasian EA; Wold LE; Amadio PC
    J Hand Surg Am; 1997 Jan; 22(1):91-8. PubMed ID: 9018620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Curettage plus cement reconstruction for treating giant cell tumor of limbs].
    Zhang Q; Cai Y; Niu X; Hao L
    Zhonghua Wai Ke Za Zhi; 1999 Dec; 37(12):730-2. PubMed ID: 11829938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience.
    Agarwal MG; Gundavda MK; Gupta R; Reddy R
    Clin Orthop Relat Res; 2018 Sep; 476(9):1773-1782. PubMed ID: 30794215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giant cell tumor of the cervical spine: a series of 22 cases and outcomes.
    Junming M; Cheng Y; Dong C; Jianru X; Xinghai Y; Quan H; Wei Z; Mesong Y; Dapeng F; Wen Y; Bin N; Lianshun J; Huimin L
    Spine (Phila Pa 1976); 2008 Feb; 33(3):280-8. PubMed ID: 18303460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of recurrent giant cell tumor of bone with malignant transformation and benign pulmonary metastases.
    Miller IJ; Blank A; Yin SM; McNickle A; Gray R; Gitelis S
    Diagn Pathol; 2010 Sep; 5():62. PubMed ID: 20860830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long bones giant cells tumors: treatment by curretage and cavity filling cementation.
    Fraquet N; Faizon G; Rosset P; Phillipeau J-; Waast D; Gouin F
    Orthop Traumatol Surg Res; 2009 Oct; 95(6):402-6. PubMed ID: 19767256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of grade III giant cell tumors of bones.
    Wang HC; Chien SH; Lin GT
    J Surg Oncol; 2005 Oct; 92(1):46-51. PubMed ID: 16180228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment options for recurrent giant cell tumors of bone.
    Balke M; Ahrens H; Streitbuerger A; Koehler G; Winkelmann W; Gosheger G; Hardes J
    J Cancer Res Clin Oncol; 2009 Jan; 135(1):149-58. PubMed ID: 18521629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curettage with cement augmentation of large bone defects in giant cell tumors with pathological fractures in lower-extremity long bones.
    Gupta SP; Garg G
    J Orthop Traumatol; 2016 Sep; 17(3):239-47. PubMed ID: 26879890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Giant cell tumor of bone: oncological and functional results of long-term follow-up.
    Oda Y; Miura H; Tsuneyoshi M; Iwamoto Y
    Jpn J Clin Oncol; 1998 May; 28(5):323-8. PubMed ID: 9703860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.